Capcita 500mg Tablets (120s)
Product Overview
Capecitabine is an oral chemotherapy medicine used to treat some cancers by converting into 5‑fluorouracil (5‑FU) inside the body to stop cancer cell growth. Available for delivery across Pakistan, this product is supplied through prescription and specialist supervision.
Key Benefits
Capecitabine may be prescribed to:
- Treat certain colorectal and breast cancers.
- Be taken at home as an oral option instead of some intravenous treatments.
- Target tumour cells by being converted to active drug in tissues.
Directions for Use
Use only under an oncologist’s direction; treatment plans are individual and monitored closely.
Adults
- Dose and schedule are set by the treating cancer specialist based on body size, other medicines, and treatment goals.
- Follow blood-test schedules and instructions exactly; do not change dose without the prescriber’s approval.
Children (Paediatric)
Routine paediatric use is not established for most indications; use only under specialist paediatric oncology care.
Pregnancy & Breastfeeding
This section gives safety guidance for pregnancy and breastfeeding.
Pregnancy
- Capecitabine is potentially harmful to an unborn baby and must not be used during pregnancy unless a specialised doctor advises otherwise.
- Effective contraception is required for both men and women during treatment and for a time after treatment as instructed by the prescriber.
Breastfeeding
Breastfeeding is not recommended during treatment and until a doctor confirms it is safe to resume.
Precautions & Interactions
Take care and discuss history and other medicines with your prescriber; regular monitoring is required.
Precautions
- Inform the doctor about liver, kidney, heart problems, or history of low blood counts.
- Report severe diarrhoea, rash on hands/feet, fever, or mouth sores quickly.
- Patients with known deficiency of DPD enzyme (an enzyme that breaks down 5‑FU) are at high risk of severe toxicity; testing may be advised.
Major Drug & Product Interactions
- Anticoagulants (e.g., warfarin): may increase bleeding risk and require frequent blood monitoring.
- Other chemotherapy or strong enzyme‑altering medicines: can increase side effects or require dose changes.
- Live vaccines are generally avoided during treatment.
Adverse Effects
Side effects are common and range from mild to serious; monitoring is essential.
Common Side Effects
- Diarrhoea and nausea.
- Hand‑foot syndrome (redness, pain or swelling on palms/soles).
- Mouth sores, loss of appetite, tiredness.
- Mild drops in blood counts causing easy bruising or infections.
Serious Side Effects
- Severe diarrhoea, fever or infection signs (may indicate low white cells) — seek urgent care.
- Chest pain, severe allergic reactions, or sudden breathlessness.
- Very severe skin reactions or signs of major liver/kidney problems.
- Signs of excessive bleeding or unexplained bruising.
If you experience serious symptoms, stop the medicine only after contacting your treating team or seek emergency help. Always carry your treatment information and follow your oncology team’s monitoring plan.
Product Overview
Capecitabine is an oral chemotherapy medicine used to treat some cancers by converting into 5‑fluorouracil (5‑FU) inside the body to stop cancer cell growth. Available for delivery across Pakistan, this product is supplied through prescription and specialist supervision.
Key Benefits
Capecitabine may be prescribed to:
- Treat certain colorectal and breast cancers.
- Be taken at home as an oral option instead of some intravenous treatments.
- Target tumour cells by being converted to active drug in tissues.
Directions for Use
Use only under an oncologist’s direction; treatment plans are individual and monitored closely.
Adults
- Dose and schedule are set by the treating cancer specialist based on body size, other medicines, and treatment goals.
- Follow blood-test schedules and instructions exactly; do not change dose without the prescriber’s approval.
Children (Paediatric)
Routine paediatric use is not established for most indications; use only under specialist paediatric oncology care.
Pregnancy & Breastfeeding
This section gives safety guidance for pregnancy and breastfeeding.
Pregnancy
- Capecitabine is potentially harmful to an unborn baby and must not be used during pregnancy unless a specialised doctor advises otherwise.
- Effective contraception is required for both men and women during treatment and for a time after treatment as instructed by the prescriber.
Breastfeeding
Breastfeeding is not recommended during treatment and until a doctor confirms it is safe to resume.
Precautions & Interactions
Take care and discuss history and other medicines with your prescriber; regular monitoring is required.
Precautions
- Inform the doctor about liver, kidney, heart problems, or history of low blood counts.
- Report severe diarrhoea, rash on hands/feet, fever, or mouth sores quickly.
- Patients with known deficiency of DPD enzyme (an enzyme that breaks down 5‑FU) are at high risk of severe toxicity; testing may be advised.
Major Drug & Product Interactions
- Anticoagulants (e.g., warfarin): may increase bleeding risk and require frequent blood monitoring.
- Other chemotherapy or strong enzyme‑altering medicines: can increase side effects or require dose changes.
- Live vaccines are generally avoided during treatment.
Adverse Effects
Side effects are common and range from mild to serious; monitoring is essential.
Common Side Effects
- Diarrhoea and nausea.
- Hand‑foot syndrome (redness, pain or swelling on palms/soles).
- Mouth sores, loss of appetite, tiredness.
- Mild drops in blood counts causing easy bruising or infections.
Serious Side Effects
- Severe diarrhoea, fever or infection signs (may indicate low white cells) — seek urgent care.
- Chest pain, severe allergic reactions, or sudden breathlessness.
- Very severe skin reactions or signs of major liver/kidney problems.
- Signs of excessive bleeding or unexplained bruising.
If you experience serious symptoms, stop the medicine only after contacting your treating team or seek emergency help. Always carry your treatment information and follow your oncology team’s monitoring plan.
| Manufacturer | Pharmasol |
|---|---|
| Ingredients | Capecitabine |
| Size | Pack of 120 Tablets |
| Prescription Required | No |
| Form | Tablets |
| PrePayment | No |
| FreeShipment | No |
| Top Selling | No |
| Hot Deals | No |
| Sponsored | No |
| Medicated | No |